Beta
36334

Role of Advanced Glycation End Products and Vascular Endothelial Growth Factor in Pathophysiology of Diabetic Retinopathy

Article

Last updated: 24 Dec 2024

Subjects

-

Tags

-

Abstract

Background: The hyperglycemic state occurring in diabetes mellitus is responsible
for formation and accumulation of advanced glycation end products (AGEs) that
participate with their receptors, receptor for advanced glycation end products (RAGE
) in the pathogenesis of vascular complications of diabetes mellitus. Intraocular
vascular endothelial growth factor (VEGF) levels have been studied in animal models
and human vitreous fluid, where the levels are found to be high in patients with active
intraocular neovascularization. Objective: To investigate the levels of AGEs ,soluble
form of RAGE (sRAGE) ,VEGF and total antioxidants (TAO) in both vitreous and
blood of diabetic patients with and without diabetic retinopathy. Study Design:
Blood and vitreous samples were collected from 30 diabetic patients, 15 with
proliferative diabetic retinopathy (PDR), 15 without retinopathy, and 15 non diabetic
control subjects. ELISA technique was used for measuring vitreous and blood levels
of AGE, sRAGE, VEGF and TAO. Results: AGEs, sRAGE and VEGF levels in blood
were significantly higher in all diabetic groups compared to controls and in PDR
patients compared to diabetic group. There were positive correlations between serum
AGEs, sRAGE and VEGF levels in both diabetic groups. Vitreous levels of AGEs and
VEGF were significantly increased in all diabetic groups compared to controls and in
PDR group compared to diabetic group. Also there were significant correlations
between these levels in both PDR and diabetic groups. Serum and vitreous TAO levels
were decreased in patients with diabetes compared to controls and in patients with
PDR compared to diabetics without retinopathy. Furthermore, Serum TAO levels
were inversely correlated with serum levels of AGEs, sRAGE and VEGF in all
diabetic patients. TAO levels in vitreous were inversely correlated with vitreous levels
of AGEs, and VEGF in all diabetic patients. Conclusion: These findings suggest that
the interaction of advanced glycation end products (AGEs), with their cellular
receptor (RAGE) and oxidative stress is implicated in the pathogenesis of diabetic
vascular complications through stimulation of VEGF.

DOI

10.21608/besps.2009.36334

Authors

First Name

Marwa

Last Name

Ahmed

MiddleName

-

Affiliation

Physiology Department, Faculty of Medicine, Assiut University

Email

mar_az_ahmed@yahoo.com

City

-

Orcid

-

First Name

Omar

Last Name

Aly

MiddleName

-

Affiliation

Ophthalmology Department, Faculty of Medicine, Assiut University

Email

-

City

-

Orcid

-

First Name

Ehab

Last Name

Wasfy

MiddleName

-

Affiliation

Ophthalmology Department, Faculty of Medicine, Assiut University

Email

-

City

-

Orcid

-

First Name

Salwa

Last Name

Wasfy

MiddleName

-

Affiliation

Physiology Department, Faculty of Medicine, Assiut University

Email

-

City

-

Orcid

-

Volume

29

Article Issue

1

Related Issue

5823

Issue Date

2009-06-01

Receive Date

2009-06-22

Publish Date

2009-06-01

Page Start

137

Page End

148

Print ISSN

1110-0842

Online ISSN

2356-9514

Link

https://besps.journals.ekb.eg/article_36334.html

Detail API

https://besps.journals.ekb.eg/service?article_code=36334

Order

12

Type

Original Article

Type Code

567

Publication Type

Journal

Publication Title

Bulletin of Egyptian Society for Physiological Sciences

Publication Link

https://besps.journals.ekb.eg/

MainTitle

Role of Advanced Glycation End Products and Vascular Endothelial Growth Factor in Pathophysiology of Diabetic Retinopathy

Details

Type

Article

Created At

22 Jan 2023